driven by the PitchBook Platform
Developer of small molecule drugs. The company develops small molecule drugs for the treatment of misfolding protein disorders such as neurodegenerative and age-related diseases.
You’re viewing a free company profile from the PitchBook Platform. To explore InFlectis BioScience’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.